In testimony today before a U.S. House of Representatives Judiciary Subcommittee, the Federal Trade Commission detailed its work to promote competition and benefit consumers, including preventing anticompetitive mergers, restricting “pay-for-delay” pharmaceutical agreements that increase prescription drug costs, stopping anticompetitive hospital mergers, and promoting competition in the high-technology and energy markets. Testifying on behalf of the […]